echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Bluebird gene therapy has shown results in the treatment of childhood encephalopathy | Yimai Meng broke the news

    Bluebird gene therapy has shown results in the treatment of childhood encephalopathy | Yimai Meng broke the news

    • Last Update: 2021-04-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recent popular reports from Yimaike ★ my country's gene editing technology has entered the stage of clinical development, and the future has comeYimai New Observation ★ Treatment of rare diseases in children! Lentiviral gene therapy is recognized by the FDA as an advanced therapy for regenerative medicineThe Biopharmaceutical Innovation Technology Conference (BPIT) will be kicked off in Shanghai from April 9th ​​to 10th, 2021.
    The four major conference venues are exciting (click to view) Focus issues).

    Participants who successfully registered for the Shanghai 2021 BPIT conference will receive a limited edition of "CAR-T Cell Therapy Industry Research Report" 2021.
    V3.
    1 produced by Xingyao Research Institute under Medical Media.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.